Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil-based vs. Sevoflurane-sufentanil Regimen for Cardiac Surgery
NCT02712528Phase 4Completed
- Sponsor
- Konkuk University Medical Center
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in coronary artery disease (CAD), sponsored by Konkuk University Medical Center. Started May 2015; status: completed.
02
Drugs
remifentanil
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02712528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712528.